EVOK

Evoke Pharma, Inc. [EVOK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

EVOK Stock Summary

Top 10 Correlated ETFs

EVOK

Top 10 Correlated Stocks

EVOK

In the News

EVOK Financial details

Company Rating
-
Market Cap
4.32M
Income
-8M
Revenue
5.18M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.39
Forward P/E
-
PEG
0.48
P/S
0.7
P/B
-3.44
P/C
-
P/FCF
-0.47
Quick Ratio
3.21
Current Ratio
3.5
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.39
EPS next Y
-
EPS next Q
-
EPS this Y
-10.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
7.24%
EPS Q/Q
15.69%
-
-
-
-
SMA20
-8.36%
SMA50
-50.1%
SMA100
-42.2%
Inst Own
-
Inst Trans
-
ROA
-99%
ROE
-530%
ROC
-1.29%
Gross Margin
92%
Oper. Margin
-169%
Profit Margin
-181%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.5-2.42
52W High
-
52W Low
-
RSI
53.4
Rel Volume
0.85
Avg Volume
55.26K
Volume
47.15K
Perf Week
18.03%
Perf Month
-14.33%
Perf Quarter
-51.92%
Perf Half Y
-61.16%
-
-
-
-
Beta
0.303
-
-
Volatility
0.1%, 0.29%
Prev Close
2.23%
Price
2.75
Change
4.56%

Something similar

Top by Market Cap
AAPL
JPM
1YD.DE
V
TL0.DE
Top Correlated ETFs
LITP
PFFD
DBB
ZHP.TO
EVAV
Top Correlated Stocks
SLDB
ADCT
MX
MBI
SRPT
Similar Market Cap
RBG.L
APTA.L
REW
9181.HK
PCSA

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 55.26K
  • Market Capitalization 4.32M
  • Employee 4
  • CEO Dr. Marilyn R. Carlson D.M.D., M.D., RAC.
  • Headquarters Solana Beach,CA,US
  • IPO Date 2013-09-25
  • Website https://www.evokepharma.com

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.